REG - TempletonEmerg.Mkt. - Update on Debt Facility

Templeton Emerging Markets Investment TrustAnnouncement

31/01/2023 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230131:nRSe4749Oa&default-theme=true

RNS Number : 4749O  Templeton Emerging Markets IT PLC  31 January 2023

31 January 2023

Templeton Emerging Markets Investment Trust PLC (the "Company")

Legal Entity Identifier: 5493002NMTB70RZBXO96

 

Amendment and Restatement of Debt Facility

The Company announces that its multicurrency revolving facility agreement with
The Bank of Nova Scotia (the "Debt Facility") has been amended and restated
pursuant to an amendment and restatement agreement dated 31 January 2023 (the
"Amendment and Restatement Agreement").

Pursuant to the Amendment and Restatement Agreement, the maturity date under
the Debt Facility has been extended to 30 January 2024. The commitment fee on
unutilised commitments has also been amended to a flat fee of 0.4 per cent.
per annum. The other material terms of the Debt Facility remain unchanged.

As at the date of this announcement, the Debt Facility is undrawn.

 Paul Manduca, Chairman of the Board commented:

"The Company's gearing policy currently permits debt of up to 20% of net asset
value. The Board has decided that renewing the Debt Facility to maintain the
flexibility to use gearing when appropriate remains appropriate."

For further information please email temitcosec@franklintempleton.com
(mailto:temitcosec@franklintempleton.com) or contact Client Dealer Services at
Franklin Templeton on free phone 0800 305 306, +44 (0) 20 7073 8690 for
overseas investors, or e-mail enquiries@franklintempleton.co.uk
(mailto:enquiries@franklintempleton.co.uk) .

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCNKDBPABKDBDN